Delveinsight

AUGUST 2, 2020

Cachexia is observed as a result of underlying diseases, including cancer, AIDS, tuberculosis, chronic heart failure, hormonal deficiency, and others. Cachexia is a complex metabolic syndrome, which is characterized by the loss of fat and muscles in the body. Cancer Cachexia Pipeline.

Marketing 94

Marketing Pharma Companies Development Hormones 94

pharmaphorum

APRIL 28, 2022

Despite the inherent difficulties, major pharma companies do take aim at rare diseases, usually with dedicated units focusing on clusters of rare diseases that afflict the same part of the body. How big pharma tackles rare diseases. It’s a different business model, if you will,” Miquel said. “So So that is the trick.

Pharma Companies 59

Pharma Companies Branding Development Marketing 59

XTalks

FEBRUARY 21, 2024

Tirzepatide’s mechanism of action involves activating two naturally produced hormones: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). MASH is known to occur in an estimated three to five percent of adults in the US.

Clinical Trials 59

Clinical Trials Clinical Trials Trials Insulin 59

pharmaphorum

JUNE 8, 2022

However, the health conditions that can arise from long-term insufficient sleep are far more serious: mental health disorders, immunodeficiency, diabetes, cardiovascular disease, obesity, hormone imbalances, and chronic pain or inflammation. Why is sleep being discussed more?

Research 98

Research Hormones Pharma Companies Development 98

Delveinsight

DECEMBER 2, 2020

Hormones – It is observed that hormones differentially influence the onset of Rheumatoid Arthritis in premenopausal and postmenopausal women. However, the role of hormones is still unclear. Various researches are going on to find the exact link between the hormone and Rheumatoid Arthritis.

Marketing 60

Marketing Hormones Antibody Development 60

pharmaphorum

DECEMBER 23, 2020

The company’s menopause drug NT-814 is heading for phase 3 development in 2021 following a mid-stage trial readout. NT-814 is a non-hormonal drug that works on the neurokinin (NK) 1,3 receptor antagonist, thus treating the vasomotor symptoms associated with the menopause. Rare disease progress.

Marketing 96

Marketing Gene Silencing Gene Drugs 96

Delveinsight

AUGUST 6, 2020

Transthyretin (TTR) is a protein that the liver produces to facilitate the transfer of thyroid hormone and vitamin A in the blood. Pharma companies like Alnylam Pharmaceuticals , Ionis Pharmaceuticals , Eidos Therapeutics, and many others are providing the thrust to the Hereditary transthyretin amyloidosis market forward.

Gene Silencing 52

Gene Silencing Protein Marketing Gene 52

XTalks

DECEMBER 22, 2021

To develop these novel RNA-based therapeutics, we saw a number of big pharma companies team up with smaller biotechs focused on developing RNA-based therapeutics. They can provide continuous real-time monitoring of metabolites, bacteria, hormones, glucose and other elements in these fluids. Minimally Invasive Devices.

Life Science 98

Life Science RNA Vaccination Vaccine 98

Pharmaceutical Technology

SEPTEMBER 23, 2022

The company focuses on small molecule, oral liquid, and solid dose products, providing formula development, method development, cleaning verification methods, tech transfer, pilot studies, commercial scale-up, and packaging. This will help determine if there are any special handling requirements. Emphasis on development.

Manufacturing 147

Manufacturing Drugs Production Packaging 147

The Pharma Data

OCTOBER 14, 2020

Amolyt Pharma – France’s Amolyt dosed the first patient in a Phase I study of AZP-3601, which is in development for the treatment of hypoparathyroidism, a rare and potentially debilitating endocrine disorder.

Clinical Trials 52

Clinical Trials Clinical Trials Manufacturing Trials 52

Pharmaceutical Technology

MARCH 16, 2023

Many politicians have cited doubts about the potential “harm” caused by puberty blockers and hormone therapies associated with gender-affirming care and concerns about incorrect treatment as major factors. While hormone therapies are allowed in the US, the age limit for this is dependent on the geographical area.

Drugs 360

Drugs Hormones Trials FDA Approval 360

Pharmaceutical Technology

APRIL 24, 2023

. “Biologics products may contain proteins that control the action of other proteins and cellular processes, genes that control production of vital proteins, modified human hormones, or cells that produce substances that suppress or activate components of the immune system.

Contract Manufacturing 130

Contract Manufacturing Manufacturing Protein Sales 130